Related Experiment Video
Updated: May 17, 2026

08:27
Alternative Cultures for Human Pluripotent Stem Cell Production, Maintenance, and Genetic Analysis
Published on: July 24, 2014
Engineering cell-material interfaces for long-term expansion of human pluripotent stem cells
Chien-Wen Chang1, Yongsung Hwang, Dave Brafman
1Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA.
Biomaterials
|November 8, 2012
Summary
Researchers developed a synthetic hydrogel matrix that supports long-term expansion of human pluripotent stem cells (hPSCs). This cost-effective matrix maintains hPSC self-renewal and differentiation potential for regenerative medicine applications.
Area of Science:
- Biomaterials Science
- Stem Cell Biology
- Regenerative Medicine
Background:
- Scalable and cost-effective synthetic matrices are crucial for human pluripotent stem cell (hPSC) expansion.
- Applications include drug screening and regenerative medicine.
Purpose of the Study:
- To develop a synthetic hydrogel matrix supporting long-term hPSC expansion.
- To investigate the impact of matrix physicochemical properties on hPSC behavior.
Main Methods:
- Development of a hydrogel matrix with synthetic heparin-mimicking moieties.
- Expansion of hPSCs on the synthetic matrix in a chemically defined medium.
- Assessment of hPSC morphology, colony formation, karyotypic stability, and differentiation potential.
Main Results:
- The synthetic matrix supported long-term hPSC expansion (≥20 passages).
- Expanded hPSCs retained characteristic morphology, colony-forming ability, karyotypic stability, and differentiation potential.
- The matrix facilitated investigation into how extracellular environment properties influence hPSC adhesion, growth, and self-renewal.
Conclusions:
- The synthetic heparin-mimicking matrix is a viable platform for cost-effective and scalable hPSC expansion.
- The matrix enables elucidation of molecular mechanisms controlling stem cell fate.
- This technology holds promise for advancing drug screening and regenerative medicine.

